Greenberg Traurig, LLP’s Post

View organization page for Greenberg Traurig, LLP, graphic

78,651 followers

Greenberg Traurig represented Moringa Acquisition Corp., a publicly-traded special purpose acquisition company, in its business combination with Silexion Therapeutics Ltd., a pioneering clinical stage, oncology-focused biotechnology company. The business combination closed on August 15, 2024, and the ordinary shares and warrants of the combined company began trading on the Nasdaq Stock Market under the tickers “SLXN” and “SLXNW”, respectively, on August 16, 2024. The GT team was led by Shareholders Mark Selinger, Gary Emmanuel, Adam Namoury, Laurie Green, and Brian Wheaton. The team also included Shareholder James Maynor, and Associates Spencer Cercone, Ricardo Crispim Leite, and Yoojin Lee. #GTNews

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics